home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

The Carlyle Group Inc. - Common Stock (NQ:CG)

45.94 +0.42 (+0.92%)

Streaming Delayed Price Updated: 12:05 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about The Carlyle Group Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics

April 24, 2025

From Acentra Health

Via GlobeNewswire

Is Carlyle Group Gaining or Losing Market Support? ↗

March 28, 2025

Via Benzinga

SoftBank Buys Silicon Valley Firm As It Goes All-In On AI ↗

March 20, 2025

This is the third big AI move the bank has made this year.

Via Talk Markets

Topics Artificial Intelligence Stocks / Equities

Masayoshi Son's SoftBank Buys Oracle-Backed Ampere For $6.5 Billion To Boost US AI Push ↗

March 19, 2025

SoftBank has acquired Oracle-backed Ampere for $6.5 billion to strengthen its AI infrastructure strategy in the U.S., marking a major step in its broader push into Arm-based computing and large-scale...

Via Benzinga

Topics Artificial Intelligence

What's Driving the Market Sentiment Around Carlyle Group? ↗

February 21, 2025

Via Benzinga

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

The Analyst Verdict: Carlyle Group In The Eyes Of 6 Experts ↗

February 12, 2025

Via Benzinga

Oppenheimer Analysts Slash Estimates For Goldman Sachs, Jefferies Amid Subdued M&A Activity ↗

March 19, 2025

Analysts expect rebound in M&A and financing activity, but uncertainties may pause it. Estimates slashed for GS and JEF, CG downgraded to Perform.

Via Benzinga

Tariffs Tangle Markets, Businesses, Investors ↗

March 12, 2025

When uncertainty spikes, our ability to look out into the future shrinks.

Via The Motley Fool

Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal ↗

March 11, 2025

Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last close. Expected to close in Q2 2025.

Via Benzinga

What's Going On With Gene Therapy Company Bluebird Bio Stock Today? ↗

February 21, 2025

bluebird bio agrees to be acquired by Carlyle Group and SK Capital, offering stockholders up to $9.84 per share in a strategic buyout.

Via Benzinga

bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital

February 21, 2025

From bluebird bio, Inc.

Via Business Wire

The Analyst Verdict: Carlyle Group In The Eyes Of 14 Experts ↗

January 03, 2025

Via Benzinga

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday? ↗

February 11, 2025

U.S.

Via Benzinga

Carlyle Group Stock Slips After Q4 Profit Miss: Retail Remains Neutral ↗

February 11, 2025

The company’s fee-earning assets under management (AUM) fell by 1% to $304 billion compared with last year.

Via Stocktwits

Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

February 04, 2025

Industry experts join board of seasoned advisors offering strategic counsel on healthcare trends and policy for the company and its portfolio of state, federal, and commercial clients

From Acentra Health

Via GlobeNewswire

Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company

February 03, 2025

From Vantive

Via GlobeNewswire

Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer

January 23, 2025

Industry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services

From Acentra Health

Via GlobeNewswire

Copia Power and Arizona Public Service (APS) Enter Into 20-Year Power Purchase Agreements for Large-Scale Solar and Storage Energy Campus

January 17, 2025

Via ACCESS Newswire

The Analyst Verdict: Carlyle Group In The Eyes Of 14 Experts ↗

December 12, 2024

Via Benzinga

Advance Auto Parts Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

November 14, 2024

Via Benzinga

Analyst Scoreboard: 12 Ratings For Carlyle Group ↗

November 08, 2024

Via Benzinga

2025 Industry Shake-Up: Goldman Highlights KKR, Raymond James, Hamilton Lane ↗

January 06, 2025

Goldman Sachs predicts winners and losers among alternative asset managers, brokers, and traditional managers in 2025, with bold rating adjustments.

Via Benzinga

Bank Of America Raises Bullish Outlook On US Brokers, Exchanges, Alternative Investments: 3 Top Picks For 2025 ↗

December 11, 2024

Bank of America bullish on U.S. brokers, asset managers and exchanges for 2025. Red wave in 2024 to open doors for crypto and alts. Blue Owl, IBKR and TW top picks; HOOD and SCHW underperformers.

Via Benzinga

TeamViewer Agrees To Acquire Carlyle-Backed 1E For $720 Million: Details ↗

December 11, 2024

TeamViewer to acquire 1E for $720 million, boosting IT performance and employee satisfaction. Deal expected to close in early 2025.

Via Benzinga

Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization

December 05, 2024

Consecutive accreditations from URAC spanning 24 years underscore the company’s unwavering compliance with rigorous standards for independent medical reviews

From Acentra Health

Via GlobeNewswire

These 3 Stocks Are Heavy Hitters in Alternative Asset Management

November 30, 2024

These three companies are known for their expertise in alternative and private asset management, an industry with attractive characteristics.

Via MarketBeat

Baxter International: Dividend Cut Because Of Restructuring ↗

November 29, 2024

Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow.

Via Talk Markets

Topics Stocks / Equities

Rubber Meets Road For Divergent Buyout-Shop Models ↗

November 11, 2024

The share prices for the private equity and credit foursome, with nearly $3 trillion of combined assets under management, jumped immediately following the election.

Via Talk Markets

Trump Trade Sparks Biggest Financial Stock Inflows In 2 Years ↗

November 11, 2024

Financial stocks rally after Trump's return to White House; investors expect deregulation and tax cuts. Goldman Sachs predicts top picks in sector.

Via Benzinga

Topics Government

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com